Europe’s Biotechs Want Flexibility When Seeking Scientific Advice
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotechs and smaller companies have called for more flexibility and informal dialogue when seeking scientific advice from Europe’s regulators and HTA bodies on the development of their investigational medicines, says a joint survey by EuropaBio and the Deerfield Institute.